Brian McNamara

Haleon Reports Sluggish First-Quarter Growth

Despite price increases, Haleon's roster of products has largely kept cheaper private-label competition at bay, although the cost-of-living squeeze and com...

Haleon Misses Revenue Estimates As North America Demand Drags

Haleon missed market estimates for third-quarter revenue, as the world's largest consumer healthcare firm grappled with weak demand for its painkillers, di...

Haleon Raises Annual Organic Revenue Growth Forecast On Steady Demand

Haleon has raised its forecast for annual organic revenue growth, as the consumer healthcare company is confident that demand for its oral and respiratory...

Haleon First Quarter Profit Misses Analyst Expectations

Haleon, the world's biggest standalone consumer health business, has reported first-quarter profit below analyst expectations.

Haleon Forecasting 4% To 6% Revenue Growth this Year

Haleon, the world's biggest standalone consumer health business, has forecast 4% to 6% organic revenue growth in 2023.

Consumer Health Firm Haleon Posts 16.1% Jump In Quarterly Sales

Haleon, the former consumer health arm of GSK, has reported a 16.1% increase in third-quarter reported revenue as it raised prices, and lifted its sales ou...

Haleon Sees Revenue Up 13.4% In First Half

British consumer healthcare company Haleon, which GSK recently officially spun off, has reported revenue growth of 13.4% (up 11.6% in t), to £5.2 bil...

GSK Names Brian McNamara As CEO Of New Spin-Off

British drugmaker GSK said on Thursday its consumer healthcare head, Brian McNamara, will take over as the chief executive officer of the unit on...

Subscribe Today

Get the app today!